Looking for a specific product?

Make a search for products & suppliers, articles & news.

Bionor Pharma Positioned for Execution of the Kick, the Kill and the Boost Strategy, Aiming Towards a Functional Cure for HIV

Bionor Pharma ASA (OSE: BIONOR) announced today results from the third quarter and first nine months of 2013. 

The Q3 report will be presented by webcast 8 November at 8.30 am CET. Link for registration and access to the webcast: http://www.media-server.com/m/p/zovaz8yn
See further information about the webcast and call numbers below.

Download the Q3 report and Q3 presentation.

 

If you would like to find out more about Bionor Pharma, please visit their website here.

Associated companies:


Related news

Latest news

Midt-Norsk Havbruk and Plastsveis enter into agreement to build smolt facility

“We have followed the development of technology for smolt production carefully for several years,

DNV GL launches on-demand, web-based forecasting at WindPower 2017

Energy traders and plant operators gain online access to hourly forecast data at plant and regional level...

International Quality Awards announced

The Chartered Quality Institute (CQI) launches a series of quality awards designed to recognize the contribution of quality professionals across the globe.

Record prices generate record operating profit

In Q1 2017 Lerøy Seafood Group (LSG) reported operating profit

New Land Based Contract

AKVA group secures new Land Based contract with Midtnork Havbruk

Offshore Wind Energy 2017, London

Oglaend System will exhibit at the Offshore Wind Energy 2017 from 6.-8. June at ExCel London. Visit us at stand N-K30.

Closed at May 17th

Seacat Liberty (YN 81) has been launched

Seacat Services latest fleet addition, Seacat Liberty, was launched May 12th, 2017.

DNV GL starts Joint Industry Project to improve assessment of site condition data for offshore wind farms

DNV GL invites industry partners to start a Joint Industry Project (JIP)..